These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 10468958)
41. Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53. Sala A; Casella I; Grasso L; Bellon T; Reed JC; Miyashita T; Peschle C Cancer Res; 1996 May; 56(9):1991-6. PubMed ID: 8616838 [TBL] [Abstract][Full Text] [Related]
42. Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis. Wang DG; Johnston CF; Buchanan KD Cancer; 1997 Aug; 80(4):668-75. PubMed ID: 9264349 [TBL] [Abstract][Full Text] [Related]
43. [Molecular bases of the programmed cell death process: implications of tumor suppressor protein p53 and other proteins in the control of cell cycle. Mechanisms of apoptotic action. Review]. Merino JJ; Cordero-Campaña MI Invest Clin; 1998 Dec; 39(4):323-58. PubMed ID: 9927805 [TBL] [Abstract][Full Text] [Related]
44. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis. Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143 [TBL] [Abstract][Full Text] [Related]
45. bcl-2/bax expression and p53 gene status in human bladder cancer: relationship to early recurrence with intravesical chemotherapy after resection. Ye D; Li H; Qian S; Sun Y; Zheng J; Ma Y J Urol; 1998 Dec; 160(6 Pt 1):2025-8; discussion 2029. PubMed ID: 9817315 [TBL] [Abstract][Full Text] [Related]
47. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. Soda G; Antonaci A; Bosco D; Nardoni S; Melis M J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183 [TBL] [Abstract][Full Text] [Related]
48. The relevance of apoptosis for cellular homeostasis and tumorigenesis in the intestine. Renehan AG; Bach SP; Potten CS Can J Gastroenterol; 2001 Mar; 15(3):166-76. PubMed ID: 11264570 [TBL] [Abstract][Full Text] [Related]
49. Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing. Backman S; Norlén O; Eriksson B; Skogseid B; Stålberg P; Crona J Anticancer Res; 2017 Feb; 37(2):705-712. PubMed ID: 28179320 [TBL] [Abstract][Full Text] [Related]
50. [Molecular biology of cell death]. Tsujimoto Y Gan To Kagaku Ryoho; 1994 Apr; 21(5):591-5. PubMed ID: 8154883 [TBL] [Abstract][Full Text] [Related]
51. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Graeber TG; Osmanian C; Jacks T; Housman DE; Koch CJ; Lowe SW; Giaccia AJ Nature; 1996 Jan; 379(6560):88-91. PubMed ID: 8538748 [TBL] [Abstract][Full Text] [Related]
52. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Sakamuro D; Eviner V; Elliott KJ; Showe L; White E; Prendergast GC Oncogene; 1995 Dec; 11(11):2411-8. PubMed ID: 8570193 [TBL] [Abstract][Full Text] [Related]
53. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression. Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405 [TBL] [Abstract][Full Text] [Related]
54. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products. Langlois NE; Lamb J; Eremin O; Heys SD J Pathol; 1997 Aug; 182(4):392-7. PubMed ID: 9306959 [TBL] [Abstract][Full Text] [Related]
55. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins. Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658 [TBL] [Abstract][Full Text] [Related]
56. Mediation of c-Myc-induced apoptosis by p53. Hermeking H; Eick D Science; 1994 Sep; 265(5181):2091-3. PubMed ID: 8091232 [TBL] [Abstract][Full Text] [Related]
57. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy. Strasser A; Huang DC; Vaux DL Biochim Biophys Acta; 1997 Oct; 1333(2):F151-78. PubMed ID: 9395285 [TBL] [Abstract][Full Text] [Related]
58. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Thomas A; El Rouby S; Reed JC; Krajewski S; Silber R; Potmesil M; Newcomb EW Oncogene; 1996 Mar; 12(5):1055-62. PubMed ID: 8649796 [TBL] [Abstract][Full Text] [Related]
59. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma. Bhatavdekar JM; Patel DD; Ghosh N; Chikhlikar PR; Trivedi TI; Suthar TP; Doctor SS; Shah NG; Balar DB Dis Colon Rectum; 1997 Jul; 40(7):785-90. PubMed ID: 9221853 [TBL] [Abstract][Full Text] [Related]
60. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. Martinez-Valdez H; Guret C; de Bouteiller O; Fugier I; Banchereau J; Liu YJ J Exp Med; 1996 Mar; 183(3):971-7. PubMed ID: 8642300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]